Yahoo Web Search

Search results

1. • 

     Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript

     Insider Monkey via Yahoo Finance· 2 days ago

     Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript May 9, 2024 Nektar Therapeutics...

2. • 

     Hair Spa Miami in Coral Gables provides extra TLC with head massages and scalp treatment - WSVN...

     7 News Miami· 6 days ago

     You’ve probably had a back massage but let’s talk about your head getting your scalp touched it’s a...

3. • Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates

     Reuters· 3 days ago

     , opens new tab blockbuster arthritis drug Humira in the coming weeks after it posted mixed results in the first three months of 2024. In the wake of February's U.S. Food and Drug Administration ...

4. • Protagonist Therapeutics Inc (PTGX) Surpasses Q1 Revenue Estimat

     Guru Focus· 5 days ago

     On May 7, 2024, Protagonist Therapeutics Inc (PTGX, Financial) unveiled its financial outcomes for the first quarter ended March 31, 2024, through its 8-K filing. The clinical-stage biopharmaceutical ...

5. • 

     Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.

     Quartz· 5 days ago

     Every pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...

6. • Amgen (NASDAQ:AMGN) Shares Down 2.7% on Insider Selling

     ETF DAILY NEWS· 6 days ago

     Amgen Inc. (NASDAQ:AMGN – Get Free Report) shares were down 2.7% on Monday after an insider sold shares in the company. The company traded as low as $301.09 and last traded at $302.91. Specifically ...

7. • 

     3 Tried and True Dividend Stocks to Buy for Your Portfolio

     InvestorPlace· 5 days ago

     Picking income stocks can be challenging. It varies year to year, but holding solid income stocks...

8. • StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)

     ETF DAILY NEWS· 2 days ago

     StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research report released on Wednesday morning. The brokerage issued a hold rating on the stock. Can-Fite ...

9. • Q2 2024 EPS Estimates for Amgen Inc. Reduced by Leerink Partnrs (NASDAQ:AMGN)

     ETF DAILY NEWS· 6 days ago

     Amgen Inc. (NASDAQ:AMGN – Free Report) – Stock analysts at Leerink Partnrs reduced their Q2 2024 earnings estimates for Amgen in a research report issued on Friday, May 3rd. Leerink Partnrs ...

10. • Journey Medical Corp Announces New Journey with the Experts Video Featuring Karan Lal, DO

      Digital Journal· 2 days ago

      Dr. Lal sits down with Journey Medical to discuss keloids, including what they are, why they occur, and how those affected can seek treatment from their local dermatology ...